TheBusinessResearchCompany.com offers Cardiovascular Drugs Global Market Report 2019 from its research database.

LONDON, GREATER LONDON, UK, June 28, 2019 /EINPresswire.com/ -- The cardiovascular drugs market expected to reach a value of nearly $86.67 billion by 2022, significantly growing at an annual growth rate of 1.2% during the forecast period. The growth in the Cardiovascular drugs market is due to increase in aging population, increase in the prevalence of cardiovascular diseases and availability of more generic drugs that reduce the cost of treatment. However, the market for cardiovascular drugs is expected to face certain restraints from several factors such as rising government interventions and rising safety regulations.

The cardiovascular drugs market consists of sales of cardiovascular drugs and related services by entities (organizations, sole traders and partnerships) that produce cardiovascular drugs to treat cardiovascular diseases. This industry includes establishments that produce anti-hypertensive drugs to prevent heart failure by controlling blood pressure and hypolipidemic drugs that reduce lipid and lipoprotein levels in the blood. It also consists of establishments, which produce antithrombotic drugs to treat arterial and venous thrombosis.

Request For A Free Sample For The Global Cardiovascular Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2134&type=smp

The global cardiovascular drugs market is further segmented based on type and geography.
By Type - The cardiovascular drugs market is segmented into anti-hypertensive drugs, hypolipidemics, anti thrombotics, other drugs for cardiovascular diseases (congestive heart failure, anti-arrhythmic and anti-anginal drugs) among these segments, the anti-hypertensive drugs market accounts for the largest share in the global Cardiovascular drugs market.
By Geography - The global cardiovascular drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, Asia Pacific was the largest region in the global cardiovascular drugs market.

Read More On The Report For The Global Cardiovascular Drugs Market At:
https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

Trends In The Cardiovascular Drugs Market
NOACs are gaining wider acceptance and are replacing traditionally used anti-coagulants such as Warfarin and Heparin. Anti-coagulants have long been used in prevention of thrombus formation in patients suffering with cardiovascular diseases. Use of NOACs makes it easier for patients to continue therapy post discharge as opposed to injections of Heparin and Warfarin which need medical assistance for administration. Some of the NOACs include Pradaxa (dabigatran etexilate) from Boehringer Ingelheim, Xarelto (rivaroxaban) from Janssen, and Eliquis (apixaban) from Bristol-Myers Squibb.

Potential Opportunities In The Cardiovascular Drugs Market
The decline in the market is due to patent expiries of a major brands of cardiovascular drugs such as Lipitor, Plavi and others. Loss of patency has increased the market scope for generic versions of the drug with a huge difference in the prices.

Major players in the global cardiovascular drugs market include Merck & Co, Sanofi S.A, Pfizer Inc, Bristol-Myers Squibb Company, Novartis AG

Cardiovascular Drugs Global Market Report 2019 is one of a series of new reports from The Business Research Company that provides cardiovascular drugs market overviews, analyzes and forecasts cardiovascular drugs market size and growth for the global cardiovascular drugs market, cardiovascular drugs market share, cardiovascular drugs market players, cardiovascular drugs market size, cardiovascular drugs market segments and geographies, cardiovascular drugs market trends, cardiovascular drugs market drivers and cardiovascular drugs market restraints, cardiovascular drugs market’s leading competitors’ revenues, profiles and market shares. The cardiovascular drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Where To Learn More
Read Cardiovascular Drugs Global Market Report 2019 from The Business Research Company for information on the following:

Markets Covered: global cardiovascular drugs market, anti-hypertensive drugs, hypolipidemics, anti thrombotics, other drugs for cardiovascular diseases (congestive heart failure, anti-arrhythmic and anti-anginal drugs)
Data Segmentations: cardiovascular drugs market size, global and by country; historic and forecast size, and growth rates for the world, 7 regions and 12 countries

Cardiovascular Drugs Market Organizations Covered: Merck & Co, Sanofi S.A, Pfizer Inc, Bristol-Myers Squibb Company, Novartis AG.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Time Series: Five years historic (2014-18) and forecast (2018-22).

Other Information And Analyses: PESTEL analysis, cardiovascular drugs market customer information, cardiovascular drugs market product/service analysis – product examples, cardiovascular drugs market trends and opportunities, drivers and restraints, key mergers and acquisitions, key metrics covered: number of enterprises, number of employees, global cardiovascular drugs market in 2019 - countries offering most new opportunities

Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.

Strategies For Participants In The Cardiovascular Drugs Industry: The report explains a number of strategies for companies in the cardiovascular drugs market, based on industry trends and company analysis.

Opportunities For Companies In The Cardiovascular Drugs Sector: The report reveals where the global cardiovascular drugs industry will put on most $ sales up to 2022.

Interested to know more about The Business Research Company?
The Business Research Company has published over 300 industry reports, covering over 2400 market segments and 56 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. Here is a list of reports from The Business Research Company similar to Cardiovascular Drugs Global Market Report 2019:

Hematology Drugs Global Market Report 2019

Pharmaceutical Drugs Market By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs) - Global Forecast To 2022
Healthcare Market By Types (Healthcare Services, Pharmaceutical Drugs, Medical Equipment, Biologics And Veterinary Healthcare), By Competitors, By Trends, By Geography And By Segments - Global Forecasts To 2022

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn